Peer Review History
| Original SubmissionJuly 30, 2025 |
|---|
|
Dear Dr. Hanewinkel, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 17 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, José Alberto Molina Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 3. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: No ********** Reviewer #1: This paper employs a discrete choice setup to study older adults’ preferences when making treatment decisions. The manuscript addresses a relevant research question, and the overall study design is adequate to investigate it. That being said, there are some important limitations that should be addressed before the manuscript can be considered for publication. I recommend to offer the authors a revise and resubmit, and encourage the authors to carefully address the concerns raised in this review. 1. Data availability: I am somewhat confused with whether the data supporting these findings will be made public upon publication. In response to the question, “Do the authors confirm that all data underlying the findings described in their manuscript are fully available without restriction?” the authors wrote: “No – some restrictions will apply.” However, they also state that “data will be held in a public repository, and will be made available after acceptance”. Why not deposit the data in a public repository now and include the link in the submitted paper? Doing so (along with providing the code used in the analyses) would have allowed us to verify the specific analytical setup and make a more comprehensive evaluation of the work. 2. Statistical power: The authors state that “Each respondent completed six tasks with two scenarios, ensuring each scenario was tested at least 15 times”. What is the justification for this minimum of 15 observations per scenario? What a priori power analysis was conducted to determine the required sample size (e.g., assumed effect sizes, desired power, alpha level, and model structure)? Please report the power analysis and indicate whether the achieved sample meets those requirements. 3. Pilot: The pilot data was included in the final dataset. This is not a standard practice. Were there any differences between the design/respondents of the pilot and the main study? 4. In the study, each participant made six choices. Choices made by the same participant are not independent observations. To draw valid inferences, the authors need to account for this lack of independence in their logistic analyses (for example, by clustering standard errors at the participant level or using an appropriate multilevel model). 5. On page 7, the authors state that “Bayesian priors were estimated based on prior clinical data.” Could the authors clarify what these Bayesian priors were used for? Please, also specify the actual priors employed and run a sensitivity check. 6. The authors include certain interaction terms between personal characteristics and choice attributes in their models. In page 8 they argue that the specific interactions to be tested were chosen based on “literature and consensus of the study team”, without providing further explanation on these statistical design choices. The authors should provide a more detailed justification of these analytical choices, referencing relevant literature. 7. Not every reader will have a solid grasp on how latent class analysis works. The paper would benefit from providing a more extensive introduction to it. 8. When running the latent class analysis, was the unit of analysis the individual or the choice? The text seems to suggest that individuals were classified into two groups, but I am not convinced. If the unit of analysis is indeed the individual, and N=333 (as reported in Table 2), then there cannot be a group with exactly 22.4% of individuals, since this would correspond to 74.5 individuals. The group should consist of either 74 individuals (22.2% of the sample) or 75 individuals (22.5%). Could the authors clarify how the multiple observations per individual were handled in this analysis and how group percentages were derived? 9. What do the authors make of the non-monotonic life expectancy preferences? (the fact that people assign a higher utility to 2 additional life expectancy years than to 5 years). What could explain these findings? I think the authors should elaborate on this further in the discussion. Reviewer #2: I find the manuscript to be timely and relevant. However, several issues need to be addressed before the paper can be considered for publication: Language and clarity: The manuscript would benefit from careful proofreading and language editing to improve readability and ensure clarity of expression. Presentation of Logit estimates: The current tables report coefficients without clearly indicating their interpretation. I recommend presenting average marginal effects, which would make the results more interpretable and policy-relevant. Sample representativeness: While the Netherlands is indeed experiencing an aging process, the sample appears to cover a specific geographic area and may not be representative of the broader population. The authors should discuss potential sample selection issues more transparently and clarify the limitations of generalizing the results. Addressing these points would strengthen the manuscript and improve its contribution to the literature. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
What matters most to older adults in treatment decision making: a discrete choice experiment. PONE-D-25-37657R1 Dear Dr. Hanewinkel, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, José Alberto Molina Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: (No Response) ********** Reviewer #1: All comments and remaining concerns have been adequately addressed. I congratulate the authors on their work. Reviewer #2: While I appreciate the authors’ efforts to revise the manuscript, the key concerns raised in my previous report have not been satisfactorily addressed. As a result, the paper still suffers from the same fundamental problems that limit its contribution and rigor. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-25-37657R1 PLOS ONE Dear Dr. Hanewinkel, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor José Alberto Molina Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .